- A Hybrid Maze Procedure for Long-Standing Persistent Atrial Fibrillation. [Review]
- ATAnn Thorac Surg 2018 Aug 14
- CONCLUSIONS: It is possible to create the complete lesion pattern of a Maze-IV procedure with a staged TS/CA hybrid procedure. The success of this "Hybrid Maze Procedure" in patients with LSPAF should be the same as that attained with an open surgical Maze-IV procedure.
- Cavotricuspid isthmus ablation using multimodality imaging in Ebstein anomaly with a mechanical tricuspid valve replacement. [Journal Article]
- HCHeartRhythm Case Rep 2018; 4(8):346-349
- Accurate detection of atrial fibrillation and atrial flutter using the electrocardiomatrix technique. [Journal Article]
- JEJ Electrocardiol 2018 Aug 11
- CONCLUSIONS: This study demonstrates that ECM is a reliable method for accurate identification of AFIB and AFL.
- Biatrial flutter circuit involving an anomalous insertion of the Bachmann bundle into the superior vena cava. [Journal Article]
- HCHeartRhythm Case Rep 2018; 4(8):353-355
- Clinical outcomes of solitary atrial flutter patients using anticoagulation therapy: a national cohort study. [Journal Article]
- EEuropace 2018 Aug 09
- CONCLUSIONS: Solitary AFL patients without anticoagulation therapy had better clinical outcomes than AFL patients developing AF in this study. Anticoagulation therapy may offer the best net clinical outcome for solitary AFL patients with a CHA2DS2-VASc score ≥4.
- Eighty-two-year-old man with a systolic murmur. [Journal Article]
- HHeart 2018 Aug 09
- An 82-year-old man with a history of coronary artery bypass surgery, hypertension and small bowel gastrointestinal stromal tumour underwent cardiac risk evaluation prior to surgical resection of his ...
An 82-year-old man with a history of coronary artery bypass surgery, hypertension and small bowel gastrointestinal stromal tumour underwent cardiac risk evaluation prior to surgical resection of his tumour. He was asymptomatic from a cardiovascular perspective, but his activity level was less than four metabolic equivalents. Physical examination was notable for a 2/6 systolic murmur at the apex. ECG showed sinus rhythm. A transthoracic echocardiogram was performed (figure 1 and online supplementary video 1).DC1SP110.1136/heartjnl-2018-313413.supp1Supplementary file 1 heartjnl;heartjnl-2018-313413v1/F1F1F1Figure 1Transthoracic echocardiography. (A) Mitral valve continuous wave Doppler and (B) tricuspid valve continuous wave Doppler.
- The Risk of Subsequent Atrial Fibrillation in Patients With Atrial Flutter: The Role of Conduction Abnormalities Reflected on the Surface Electrocardiogram. [Letter]
- CJCan J Cardiol 2018 Jun 05
- A fluttering coronary event. [Journal Article]
- JFJ Family Med Prim Care 2018 Mar-Apr; 7(2):468-470
- Acute coronary syndrome (ACS) is a term used to describe a spectrum of diseases associated with sudden reduced blood flow to the heart. Coronary artery thromboembolism is recognized as an important n...
Acute coronary syndrome (ACS) is a term used to describe a spectrum of diseases associated with sudden reduced blood flow to the heart. Coronary artery thromboembolism is recognized as an important nonatherosclerotic cause of acute myocardial infarctions in 2.9% of ACS cases, with a long-term outcome indicating that coronary embolism patients represent a high-risk subpopulation. There are various risk factors for developing a coronary thromboembolism, with atrial fibrillation being the most frequently reported cause. Herein, we are presenting a case of a 65-year-old female patient who presented to the emergency department with sudden-onset pressure-like chest pain diagnosed as ACS due to nonatherosclerotic thromboembolism secondary to atrial flutter.
- Cardiac Rhythm Disturbances in Hemodialysis Patients: Early Detection Using an Implantable Loop Recorder and Correlation With Biological and Dialysis Parameters. [Journal Article]
- JCJACC Clin Electrophysiol 2018; 4(3):397-408
- CONCLUSIONS: ILR may be considered in HD patients prone to significant conduction disorders, ventricular arrhythmia, or atrial fibrillation or flutter to allow early identification and initiation of adequate treatment. Therapeutic strategies reducing serum potassium variability could decrease the rate of SD in these patients. (Implantable Loop Recorder in Hemodialysis Patients [RYTHMODIAL]; NCT01252823).
New Search Next
- StatPearls [BOOK]
- BOOKStatPearls Publishing: Treasure Island (FL)
- Esmolol (esmolol hydrochloride) is an intravenous cardioselective beta-1 adrenergic antagonist. Esmolol is FDA-approved for short-term duration use in control of supraventricular tachycardia, such as...
Esmolol (esmolol hydrochloride) is an intravenous cardioselective beta-1 adrenergic antagonist. Esmolol is FDA-approved for short-term duration use in control of supraventricular tachycardia, such as a rapid ventricular rate in patients with atrial fibrillation or atrial flutter. Esmolol is used in various settings including urgent care, perioperatively, and postoperatively. It is also indicated in sinus tachycardia, where a rapid rate requires intervention secondary to other comorbidities. Esmolol is further FDA-approved for tachycardia and hypertension induced by intubation. Off-label, it is used for rate and rhythm control in aortic dissection, acute coronary syndrome, non-ST elevation myocardial infarction, hypertensive emergencies, thyrotoxicosis, refractory ventricular tachycardia, refractory to defibrillation ventricular fibrillation, and to decrease catecholamine response during electroconvulsive therapy.